FDA Inspection
Elite Laboratories Inc.Elite Laboratories Inc. – FDA Inspection, Apr 24, 2017
Record Details
This FDA Inspection record concerns Elite Laboratories Inc., with an inspection on April 24, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · cd263b5f-0f81-4d6f-b48c-1064e947d029
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1014880
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Elite Laboratories Inc.
10| Date | Classification | Office | Project area |
|---|---|---|---|
| August 1, 2025 | Not classified | New Jersey District Office | |
| March 13, 2020 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 21, 2020 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 28, 2018 | Not classified | New Jersey District Office | |
| February 2, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Elite Laboratories Inc.
- FDA Inspection 1269549 - 2025-08-01
- FDA Inspection 1120647 - 2020-03-13
- FDA Inspection 1119158 - 2020-01-21
- FDA Inspection 1069135 - 2018-09-28
- FDA Inspection 1042332 - 2018-02-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.